Most Medical Groups (Like Kaiser) will not approve it because of the expense and it is considered experimental for AA treatment. Xeljanz is approved by the FDA for Rheumatoid Arthritis. At $2,083 per month it adds up quickly is why people look outside the US.
Any mention of products and services on Alopecia World is for informational purposes only; it does not imply a recommendation or endorsement by Alopecia World. Nor should any statement or representation on this site be construed as professional, medical or expert advice, or as pre-screened or endorsed by Alopecia World. Alopecia World is not responsible or liable for any of the views, opinions or conduct, online or offline, of any user or member of Alopecia World.